Abstract
We measured SARS-CoV-2 antibody levels in serum samples from 1,471 mother/newborn dyads and found efficient transplacental transfer of SARS-CoV-2 IgG antibodies in 72 of 83 seropositive pregnant women. Transfer ratios >1.0 were observed among women with an asymptomatic SARS-CoV-2 infection as well as those with mild, moderate and severe COVID-19. Our findings demonstrate the potential for maternally-derived antibodies to provide neonatal protection from SARS-CoV-2 infection.
Competing Interest Statement
SEH has received consultancy fee from Sanofi Pasteur, Lumen, Novavax, and Merck for work unrelated to this report. All other authors declare no competing interests related to this work.
Funding Statement
Funding for this study was provided in part by a Childrens Hospital of Philadelphia Foerderer Grant for Excellence to KMP.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Institutional Review Board of the University of Pennsylvania approved this study with waiver of informed consent.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
De-identified individual-level data are available upon reasonable request to SEH and KMP at hensley{at}pennmedicine.upenn.edu and karen.puopolo{at}pennmedicine.upenn.edu.
Abbreviations
- COVID-19
- coronavirus disease 2019
- ELISA
- enzyme-linked immunosorbent assay
- ICD-10
- International Classification of Diseases, 10th revision
- IgG
- Immunoglobulin G
- IgM
- Immunoglobulin M
- IUGR
- intrauterine growth restriction
- NP
- nasopharyngeal
- OD
- optical density
- PBS-T
- phosphate-buffered saline supplemented with Tween-20
- PCR
- polymerase chain reaction
- RBD
- receptor binding domain
- SARS-CoV-2
- severe acute respiratory syndrome coronavirus 2